Glenmark to launch Ryaltris, their global anti-allergy brand, in Russia and other CIS countries after the divestment ... Nov 30
Atopic dermatitis is a chronic inflammatory disease of the skin that can be debilitating, and severe disease can significantly impact many aspects of life for ... Nov 30
Hon'ble Prime Minister's leadership vision, in-depth understanding and knowledge of the facts guided us in facilitating the interactions and discussions on the ... Nov 30
The Robotic system has an advanced computed program that relays precise information about the knee with 3D mapping.... Nov 27
Xofluza for the prevention of influenza following contact with an infected person... Nov 27
Laurus Labs to acquire 72.55 per cent of Richcore’s shares for a value of Rs 246.7 crores... Nov 26
DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top-ranked companies in terms of Corporate ... Nov 26
Latest FDA News Nov 26, 2020... Nov 26
The NMPA has approved a dosing label update in China for AstraZeneca’s Lokelma to include patients with hyperkalaemia on chronic haemodialysis.... Nov 25
Testosterone Gel, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.... Nov 25
Piramal Sarvajal, the safe drinking water initiative of Piramal Foundation launched a tool named Composite Water Vulnerability Index at its recent Webinar on ‘Sustainable Water ... Nov 25
Bristol Myers Squibb announced the approval of Opdivo for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma ... Nov 25
Tacrolimus Capsules are the generic equivalent of Prograf Capsules of Astellas Pharma US, Inc. and are indicated for the prophylaxis of organ rejection.... Nov 25
The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ... Nov 23
... Nov 23
The EC has approved MenQuadfi for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.... Nov 23
Currently no vaccine is available for respiratory syncytial virus... Nov 23
Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease... Nov 23
An anti-tissue factor pathway inhibitor being evaluated for the treatment of people with severe hemophilia A or B, with or without inhibitors.... Nov 23
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ... Nov 23
GSK and MMV today presented positive data from the TEACH study of tafenoquine, an 8-aminoquinoline, for the prevention of relapse of Plasmodium vivax malaria ... Nov 20
... Nov 19
Clinical evidence for this device demonstrates safety and efficacy for people suffering from mitral regurgitation... Nov 18
Under the terms of the transaction, Catalent acquires Bone Therapeutics’ cell therapy manufacturing subsidiary, SCTS, for gross proceeds of €12 million... Nov 18
-Advertisements-
Friday, June 14, 2024
